These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
662 related items for PubMed ID: 23142380
1. Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis. Wu CF, Chiang WC, Lai CF, Chang FC, Chen YT, Chou YH, Wu TH, Linn GR, Ling H, Wu KD, Tsai TJ, Chen YM, Duffield JS, Lin SL. Am J Pathol; 2013 Jan; 182(1):118-31. PubMed ID: 23142380 [Abstract] [Full Text] [Related]
3. Putative endothelial progenitor cells do not promote vascular repair but attenuate pericyte-myofibroblast transition in UUO-induced renal fibrosis. Yang J, Wang M, Zhu F, Sun J, Xu H, Chong Lee Shin OL, Zhao Z, Pei G, Zhu H, Cao C, He X, Huang Y, Ma Z, Liu L, Wang L, Ning Y, Liu W, Xu G, Wang X, Zeng R, Yao Y. Stem Cell Res Ther; 2019 Mar 21; 10(1):104. PubMed ID: 30898157 [Abstract] [Full Text] [Related]
4. Integrin β8 prevents pericyte-myofibroblast transition and renal fibrosis through inhibiting the TGF-β1/TGFBR1/Smad3 pathway in diabetic kidney disease. Cao Y, Su H, Zeng J, Xie Y, Liu Z, Liu F, Qiu Y, Yi F, Lin J, Hammes HP, Zhang C. Transl Res; 2024 Mar 21; 265():36-50. PubMed ID: 37931653 [Abstract] [Full Text] [Related]
6. LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1. Ren S, Johnson BG, Kida Y, Ip C, Davidson KC, Lin SL, Kobayashi A, Lang RA, Hadjantonakis AK, Moon RT, Duffield JS. Proc Natl Acad Sci U S A; 2013 Jan 22; 110(4):1440-5. PubMed ID: 23302695 [Abstract] [Full Text] [Related]
14. Cellular Changes Consistent With Epithelial-Mesenchymal Transition and Fibroblast-to-Myofibroblast Transdifferentiation in the Progression of Experimental Endometriosis in Baboons. Zhang Q, Duan J, Olson M, Fazleabas A, Guo SW. Reprod Sci; 2016 Oct 22; 23(10):1409-21. PubMed ID: 27076446 [Abstract] [Full Text] [Related]
15. Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: role of inhibiting TGF-beta-induced epithelial-to-mesenchymal transition. Park SH, Choi MJ, Song IK, Choi SY, Nam JO, Kim CD, Lee BH, Park RW, Park KM, Kim YJ, Kim IS, Kwon TH, Kim YL. J Am Soc Nephrol; 2007 May 22; 18(5):1497-507. PubMed ID: 17389738 [Abstract] [Full Text] [Related]
16. Profibrotic effects of angiotensin II and transforming growth factor beta on feline kidney epithelial cells. van Beusekom CD, Zimmering TM. J Feline Med Surg; 2019 Aug 22; 21(8):780-787. PubMed ID: 30345862 [Abstract] [Full Text] [Related]
18. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Humphreys BD, Lin SL, Kobayashi A, Hudson TE, Nowlin BT, Bonventre JV, Valerius MT, McMahon AP, Duffield JS. Am J Pathol; 2010 Jan 22; 176(1):85-97. PubMed ID: 20008127 [Abstract] [Full Text] [Related]
19. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis. Li YK, Ma DX, Wang ZM, Hu XF, Li SL, Tian HZ, Wang MJ, Shu YW, Yang J. Pharmacol Res; 2018 May 22; 131():102-111. PubMed ID: 29530599 [Abstract] [Full Text] [Related]
20. Midbody plays an active role in fibroblast-myofibroblast transition by mediating TGF-β signaling. Jung SW, Kim SM, Kim A, Park SH, Moon JY, Lee SH. FASEB J; 2022 May 22; 36(5):e22272. PubMed ID: 35436011 [Abstract] [Full Text] [Related] Page: [Next] [New Search]